Efficacy and Safety Study of Entecavir Plus Tenofovir in Patients With Chronic Hepatitis B Who Failed Previous Treatment
NCT01063036
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
144
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Hepatitis B
Interventions
DRUG:
Entecavir
DRUG:
Tenofovir
Sponsor
Bristol-Myers Squibb